tiprankstipranks
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR
US Market
XFOR
X4 Pharmaceuticals
RESEARCH TOOLSreports
Want to see XFOR full AI Analyst Report?

X4 Pharmaceuticals (XFOR) Income Statement

1,114 Followers

X4 Pharmaceuticals Income Statement

Last quarter (Q4 2025), X4 Pharmaceuticals's total revenue was $2.57M, an increase of 79.08% from the same quarter last year. In Q4, X4 Pharmaceuticals's net income was $-23.93M. See X4 Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 35.11M$ 2.56M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 28.86M$ 1.76M$ 0.00$ 0.00$ -1.89M
Operating Expenses
$ 116.24M$ 38.16M$ 107.52M$ 87.57M$ 73.46M
Depreciation and Amortization
$ 1.28M$ 796.00K$ 419.00K$ 513.00K$ 1.89M
EBITDA
$ -85.61M$ -27.58M$ -94.89M$ -89.33M$ -73.46M
Operating Income
$ -86.88M$ -36.40M$ -107.52M$ -87.57M$ -75.35M
Other Income/Expenses
$ 7.72M$ -739.00K$ 6.43M$ -6.27M$ -13.33M
Pretax Income
$ -79.16M$ -37.14M$ -101.09M$ -93.84M$ -88.68M
Net Income
$ -79.20M$ -37.45M$ -101.17M$ -93.87M$ -88.70M
Per Share Metrics
Basic EPS
$ -1.87$ -5.59$ -17.07$ -45.60$ -119.58
Diluted EPS
$ -1.87$ -5.59$ -17.07$ -45.60$ -119.58
Weighted Average Shares Outstanding
 42.29M 6.70M 5.93M 2.12M 858.30K
Weighted Average Shares Outstanding (Diluted)
 42.29M 6.70M 5.93M 2.12M 858.30K
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History